Article(id=1330233147515581295, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233139936473897, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.10.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1669910400000, receivedDateStr=2022-12-02, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795081896904, onlineDateStr=2026-11-19, pubDate=1696867200000, pubDateStr=2023-10-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795081896904, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795081896904, creator=13701087609, updateTime=1795081896904, updator=13701087609, issue=Issue{id=1330233139936473897, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='10', pageStart='1403', pageEnd='1533', issueExtLink='null', onlineDate='null', pubDate='1696867200000', pubDateStr='2023-10-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795081895097, creator='13701087609', updateTime=1795082580049, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330236013437366325, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233139936473897, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330236013437366326, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233139936473897, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1403, endPage=1410, ext={EN=ArticleExt(id=1330233147712713584, articleId=1330233147515581295, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Advances in Gene Therapy for Inherited Retinal Diseases, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Inherited retinal diseases(IRD) are an important cause of irreversible vision loss or blindness, whose prognosis is poor, and clinically effective intervention methods are lacking. Gene therapy has created new possibilities for IRD treatment. Adeno-associated viral(AAV) is a widely used viral gene therapy vector with application prospects. This paper briefly describes the feasibility of AVV vectors in ocular application, focuses on the preclinical and clinical progress of the application of AAV delivery system for IRD treatment, evaluates the safety and efficacy based on the obtained data, and summarizes the influencing factors of gene therapy for IRD, as well as looks forward to the future research directions, providing references for the technological innovation of IRD treatment and the subsequent product development of AAV vectors.

, authors=Chuqiao LIU1, 2, 3, Peng ZHANG2, 3, Lili FU1, 2, 3, Qiaoyu TAO1, 2, 3, Yunliang QIU3, 4, *, authorsList=Chuqiao LIU, Peng ZHANG, Lili FU, Qiaoyu TAO, Yunliang QIU, authorCompany=null, correspAuthors=Yunliang QIU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330233147972760433, articleId=1330233147515581295, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=遗传性视网膜疾病基因治疗的研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

遗传性视网膜疾病(IRD)是造成患者不可逆视力丧失或失明的重要原因,其预后差,临床缺乏有效的干预手段。基因治疗药物为该类疾病治疗创造了新的可能。腺相关病毒(AAV)是目前基因治疗中应用较广泛、较有前景的病毒载体之一。该文简述了AVV载体眼部应用的可行性,重点阐述了应用AAV递送系统治疗IRD的临床前及临床进展,并结合取得的数据评估其安全性及有效性。最后总结了基因治疗IRD的影响因素,展望今后的研究方向,以期为IRD治疗技术创新、AAV载体后续产品研发提供参考。

, authors=刘楚乔1, 2, 3, 张鹏2, 3, 付莉莉1, 2, 3, 陶巧玉1, 2, 3, 邱云良3, 4, *, authorsList=刘楚乔, 张鹏, 付莉莉, 陶巧玉, 邱云良, authorCompany=null, correspAuthors=邱云良, authorNote=

刘楚乔(1995—),女,硕士,从事药理学研究。

, correspAuthorsNote=
邱云良(1978—),男,研究员,从事药物毒理学研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=dZ6RhgQt12ICvSo4ZGu2mg==, magXml=wMkrpXiQtEX4xIV4kN0pxw==, pdfUrl=null, pdf=H7Z9rcr5i4QdgPksGGLJUw==, pdfFileSize=1544319, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=NPZzBUnekkPMzmBUQAfMoA==, mapNumber=null, fund=null)}, authors=[Author(id=1330233148580934527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233148685792131, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233148580934527, language=EN, stringName=Chuqiao LIU, firstName=Chuqiao, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013
2.Yangtze Delta Pharmaceutical College, Nantong 226133
3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233148757095300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233148580934527, language=CN, stringName=刘楚乔, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.安徽中医药大学药学院,安徽 合肥 230013
2.南通市海门长三角药物高等研究院,江苏 南通 226133
3.益诺思生物技术南通有限公司,江苏 南通 226000, bio={"content":"

刘楚乔(1995—),女,硕士,从事药理学研究。

"}, bioImg=null, bioContent=

刘楚乔(1995—),女,硕士,从事药理学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233148199252850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=1., ext=[AuthorCompanyExt(id=1330233148207641459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013), AuthorCompanyExt(id=1330233148216030068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.安徽中医药大学药学院,安徽 合肥 230013)]), AuthorCompany(id=1330233148295721845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=2., ext=[AuthorCompanyExt(id=1330233148308304758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Yangtze Delta Pharmaceutical College, Nantong 226133), AuthorCompanyExt(id=1330233148320887671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南通市海门长三角药物高等研究院,江苏 南通 226133)]), AuthorCompany(id=1330233148392190840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=3., ext=[AuthorCompanyExt(id=1330233148404773753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000), AuthorCompanyExt(id=1330233148413162362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.益诺思生物技术南通有限公司,江苏 南通 226000)])]), Author(id=1330233148824204166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233148899701641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233148824204166, language=EN, stringName=Peng ZHANG, firstName=Peng, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2.Yangtze Delta Pharmaceutical College, Nantong 226133
3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233148954227594, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233148824204166, language=CN, stringName=张鹏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2.南通市海门长三角药物高等研究院,江苏 南通 226133
3.益诺思生物技术南通有限公司,江苏 南通 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233148295721845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=2., ext=[AuthorCompanyExt(id=1330233148308304758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Yangtze Delta Pharmaceutical College, Nantong 226133), AuthorCompanyExt(id=1330233148320887671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南通市海门长三角药物高等研究院,江苏 南通 226133)]), AuthorCompany(id=1330233148392190840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=3., ext=[AuthorCompanyExt(id=1330233148404773753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000), AuthorCompanyExt(id=1330233148413162362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.益诺思生物技术南通有限公司,江苏 南通 226000)])]), Author(id=1330233149029725068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233149138776976, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149029725068, language=EN, stringName=Lili FU, firstName=Lili, middleName=null, lastName=FU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013
2.Yangtze Delta Pharmaceutical College, Nantong 226133
3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233149210080145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149029725068, language=CN, stringName=付莉莉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.安徽中医药大学药学院,安徽 合肥 230013
2.南通市海门长三角药物高等研究院,江苏 南通 226133
3.益诺思生物技术南通有限公司,江苏 南通 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233148199252850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=1., ext=[AuthorCompanyExt(id=1330233148207641459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013), AuthorCompanyExt(id=1330233148216030068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.安徽中医药大学药学院,安徽 合肥 230013)]), AuthorCompany(id=1330233148295721845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=2., ext=[AuthorCompanyExt(id=1330233148308304758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Yangtze Delta Pharmaceutical College, Nantong 226133), AuthorCompanyExt(id=1330233148320887671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南通市海门长三角药物高等研究院,江苏 南通 226133)]), AuthorCompany(id=1330233148392190840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=3., ext=[AuthorCompanyExt(id=1330233148404773753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000), AuthorCompanyExt(id=1330233148413162362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.益诺思生物技术南通有限公司,江苏 南通 226000)])]), Author(id=1330233149285577619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233149369463703, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149285577619, language=EN, stringName=Qiaoyu TAO, firstName=Qiaoyu, middleName=null, lastName=TAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013
2.Yangtze Delta Pharmaceutical College, Nantong 226133
3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233149436572568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149285577619, language=CN, stringName=陶巧玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.安徽中医药大学药学院,安徽 合肥 230013
2.南通市海门长三角药物高等研究院,江苏 南通 226133
3.益诺思生物技术南通有限公司,江苏 南通 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233148199252850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=1., ext=[AuthorCompanyExt(id=1330233148207641459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013), AuthorCompanyExt(id=1330233148216030068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.安徽中医药大学药学院,安徽 合肥 230013)]), AuthorCompany(id=1330233148295721845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=2., ext=[AuthorCompanyExt(id=1330233148308304758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Yangtze Delta Pharmaceutical College, Nantong 226133), AuthorCompanyExt(id=1330233148320887671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南通市海门长三角药物高等研究院,江苏 南通 226133)]), AuthorCompany(id=1330233148392190840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=3., ext=[AuthorCompanyExt(id=1330233148404773753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000), AuthorCompanyExt(id=1330233148413162362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.益诺思生物技术南通有限公司,江苏 南通 226000)])]), Author(id=1330233149495292826, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=ylqiu@innostar.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233149583373213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149495292826, language=EN, stringName=Yunliang QIU, firstName=Yunliang, middleName=null, lastName=QIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, 4, *, address=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000
4.Shanghai InnoStar Bio-Tech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233149650482078, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149495292826, language=CN, stringName=邱云良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, 4, *, address=3.益诺思生物技术南通有限公司,江苏 南通 226000
4.中国医药工业研究总院上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233148392190840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=3., ext=[AuthorCompanyExt(id=1330233148404773753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000), AuthorCompanyExt(id=1330233148413162362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.益诺思生物技术南通有限公司,江苏 南通 226000)]), AuthorCompany(id=1330233148484465531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=4., ext=[AuthorCompanyExt(id=1330233148492854140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148484465531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shanghai InnoStar Bio-Tech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330233148501242749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148484465531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.中国医药工业研究总院上海益诺思生物技术股份有限公司,上海 201203)])])], keywords=[Keyword(id=1330233149763728287, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, language=EN, orderNo=1, keyword=inherited retinal disease), Keyword(id=1330233149893751712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, language=EN, orderNo=2, keyword=adeno-associated viral), Keyword(id=1330233149969249185, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, language=EN, orderNo=3, keyword=gene therapy), Keyword(id=1330233150048940962, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, language=EN, orderNo=4, keyword=safety), Keyword(id=1330233151642776483, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, language=CN, orderNo=1, keyword=遗传性视网膜疾病), Keyword(id=1330233151705691044, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, language=CN, orderNo=2, keyword=腺相关病毒), Keyword(id=1330233151764411301, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, language=CN, orderNo=3, keyword=基因治疗), Keyword(id=1330233151856685990, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, language=CN, orderNo=4, keyword=安全性)], refs=[Reference(id=1330233152049623976, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=GALVIN O, CHI G, BRADY L, et al. The impact of inherited retinal diseases in the Republic of Ireland(ROI) and the United Kingdom(UK) from a cost-of-illness perspective[J]. Clin Ophthalmol, 2020, 14: 707-719., articleTitle=null, refAbstract=null), Reference(id=1330233152116732841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=GONG J, CHEUNG S, FASSO-OPIE A, et al. The impact of inherited retinal diseases in the United States of America(US) and Canada from a cost-of-illness perspective[J]. Clin Ophthalmol, 2021, 15: 2855-2866., articleTitle=null, refAbstract=null), Reference(id=1330233152196424618, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=FENNER B J, TAN T E, BARATHI A V, et al. Gene-based therapeutics for inherited retinal diseases [J]. Front Genet,2022, 12: 794805., articleTitle=null, refAbstract=null), Reference(id=1330233152259339179, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=HANANY M, RIVOLTA C, SHARON D. Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases [J]. Proc Natl Acad Sci U S A, 2020, 117(5): 2710-2716., articleTitle=null, refAbstract=null), Reference(id=1330233152330642348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=DIAKATOU M, MANES G, BOCQUET B, et al. Genome editing as a treatment for the most prevalent causative genes of autosomal dominant retinitis pigmentosa [J]. Int J Mol Sci, 2019, 20(10): 2542., articleTitle=null, refAbstract=null), Reference(id=1330233152393556909, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=RIVOLTA C, SHARON D, DEANGELIS M M, et al. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns [J]. Hum Mol Genet, 2002,11(10): 1219-1227., articleTitle=null, refAbstract=null), Reference(id=1330233152452277166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=DAIGER S P, SULLIVAN L S, BOWNE S J. Genes and mapped loci causing retinal diseases [EB/OL]. (2022-10-07)[2022-10-17]. https://web.sph.uth.edu/RetNet/disease.htm., articleTitle=null, refAbstract=null), Reference(id=1330233152515191727, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=KEELER A M, FLOTTE T R. Recombinant adeno-associated virus gene therapy in light of Luxturna(and Zolgensma and Glybera): where are we, and how did we get here? [J]. Annu Rev Virol, 2019, 6(1): 601-621., articleTitle=null, refAbstract=null), Reference(id=1330233152573911984, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Y H, RAJALA A, CAO B, et al. Cell-specific promoters enable lipid-based nanoparticles to deliver genes to specific cells of the retina in vivo [J]. Theranostics, 2016,6(10): 1514-1527., articleTitle=null, refAbstract=null), Reference(id=1330233152636826545, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=REN D H, FISSON S, DALKARA D, et al. Immune responses to gene editing by viral and non-viral delivery vectors used in retinal gene therapy [J]. Pharmaceutics,2022, 14(9): 1973., articleTitle=null, refAbstract=null), Reference(id=1330233152695546802, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=APAOLAZA P S, DELGADO D, DEL POZO-RODRÍGUEZ A, et al. A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases [J]. Int J Pharm, 2014, 465(1/2): 413-426., articleTitle=null, refAbstract=null), Reference(id=1330233152754267059, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=PURAS G, MASHAL M, ZÁRATE J, et al. A novel cationic niosome formulation for gene delivery to the retina [J]. J Control Release, 2014, 174: 27-36., articleTitle=null, refAbstract=null), Reference(id=1330233152821375924, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=AIL D, MALKI H, ZIN E A, et al. Adeno-associated virus(AAV)-based gene therapies for retinal diseases: where are we? [J]. Appl Clin Genet, 2023, 16: 111-130., articleTitle=null, refAbstract=null), Reference(id=1330233152884290485, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=GHOSH A, YUE Y, LAI Y, et al. A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner [J]. Mol Ther, 2008,16(1): 124-130., articleTitle=null, refAbstract=null), Reference(id=1330233152943010742, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=滕小龙,史硕博.CRISPR/Cas9 系统在基因组编辑中的优化与发展[J].合成生物学,2023,4(1):67-85., articleTitle=null, refAbstract=null), Reference(id=1330233153039479735, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=LEROY B P, FISCHER M D, FLANNERY J G, et al. Gene therapy for inherited retinal disease: long-term durability of effect [J]. Ophthalmic Res, 2023, 66(1): 179-196., articleTitle=null, refAbstract=null), Reference(id=1330233153114977208, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=DHOOGE P P, VALKENBURG D, HOYNG C B. Gene therapy for inherited retinal diseases [M]// GAO X R. Genetics and genomics of eye disease. Amsterdam: Elsevier,2020: 279-295., articleTitle=null, refAbstract=null), Reference(id=1330233153177891769, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=HAMEL C. Retinitis pigmentosa [J]. Orphanet J Rare Dis, 2006, 1(1): 40., articleTitle=null, refAbstract=null), Reference(id=1330233153253389242, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=沈科炯,沈吟.遗传性视网膜疾病腺相关病毒载体基因治疗新进展[J].中华眼底病杂志,2020,36(3):242-248., articleTitle=null, refAbstract=null), Reference(id=1330233153312109499, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=MERCAU M E, AKALU Y T, MAZZONI F, et al. Inflammation of the retinal pigment epithelium drives early-onset photoreceptor degeneration in MERTK-associated retinitis pigmentosa [J]. Sci Adv, 2023, 9(3): eade9459., articleTitle=null, refAbstract=null), Reference(id=1330233153404384188, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=GHAZI N G, ABBOUD E B, NOWILATY S R, et al. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phaseⅠtrial [J]. Hum Genet, 2016, 135(3): 327-343., articleTitle=null, refAbstract=null), Reference(id=1330233153484075965, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=HERNÁNDEZ-JUÁREZ J, RODRíGUEZ-URIBE G, BOROOAH S. Toward the treatment of inherited diseases of the retina using CRISPR-based gene editing [J]. Front Med (Lausanne), 2021, 8: 698521., articleTitle=null, refAbstract=null), Reference(id=1330233153572156350, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=SUZUKI K, TSUNEKAWA Y, HERNANDEZ-BENITEZ R, et al. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration [J]. Nature,2016, 540(7631): 144-149., articleTitle=null, refAbstract=null), Reference(id=1330233153710568383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=DE SILVA S R, ARNO G, ROBSON A G, et al. The X-linked retinopathies: physiological insights, pathogenic mechanisms, phenotypic features and novel therapies [J]. Prog Retinal Eye Res, 2021, 82: 100898., articleTitle=null, refAbstract=null), Reference(id=1330233153777677248, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=CEHAJIC-KAPETANOVIC J, XUE K, MARTINEZ-FERNANDEZ DE LA CAMARA C, et al. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR [J]. Nat Med,2020, 26(3): 354-359., articleTitle=null, refAbstract=null), Reference(id=1330233153848980417, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=MARTINEZ VELAZQUEZ L A, BALLIOS B G. The next generation of molecular and cellular therapeutics for inherited retinal disease [J]. Int J Mol Sci, 2021, 22(21): 11542., articleTitle=null, refAbstract=null), Reference(id=1330233153924477890, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=WU Y D, WAN X L, ZHAO D D, et al. AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa [J]. Nat Commun,2023, 14(1): 4923., articleTitle=null, refAbstract=null), Reference(id=1330233153995781059, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=KISER P D. Retinal pigment epithelium 65 kDa protein(RPE65): an update [J]. Prog Retinal Eye Res,2022, 88: 101013., articleTitle=null, refAbstract=null), Reference(id=1330233154071278532, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=PANG J J, CHANG B, HAWES N L, et al. Retinal degeneration 12(rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis(LCA) [J]. Mol Vis, 2005, 11(17): 152-162., articleTitle=null, refAbstract=null), Reference(id=1330233154134193093, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=LAI C M, YU M J, BRANKOV M, et al. Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65 - / - knockout mouse eye results in limited rescue [J]. Genet Vaccines Ther, 2004, 2(1): 3., articleTitle=null, refAbstract=null), Reference(id=1330233154197107654, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=ACLAND G M, AGUIRRE G D, BENNETT J, et al. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness [J]. Mol Ther, 2005, 12(6): 1072-1082., articleTitle=null, refAbstract=null), Reference(id=1330233154264216519, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=WELEBER R G, PENNESI M E, WILSON D J, et al. Results at 2 years after gene therapy for RPE65-deficient Leber congenital amaurosis and severe early-childhood-onset retinal dystrophy [J]. Ophthalmology, 2016, 123(7): 1606-1620., articleTitle=null, refAbstract=null), Reference(id=1330233154331325384, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=PENNESI M E, WELEBER R G, YANG P, et al. Results at 5 years after gene therapy for RPE65-deficient retinal dystrophy [J]. Hum Gene Ther, 2018, 29(12): 1428-1437., articleTitle=null, refAbstract=null), Reference(id=1330233154394239945, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=JO D H, SONG D W, CHO C S, et al. CRISPR-Cas9-mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis[J]. Sci Adv, 2019, 5(10): eaax1210., articleTitle=null, refAbstract=null), Reference(id=1330233154461348810, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=MAEDER M L, STEFANIDAKIS M, WILSON C J, et al. Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10 [J]. Nat Med,2019, 25(2): 229-233., articleTitle=null, refAbstract=null), Reference(id=1330233154532651979, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=PHILIPPIDIS A. One small dose, one giant leap for CRISPR gene editing [J]. Hum Gene Ther, 2020, 31(7/8):402-404., articleTitle=null, refAbstract=null), Reference(id=1330233156151653326, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=LEON L M, ZHANG W, SAHU B, et al. A MiniCEP290 gene replacement therapy to treat CEP290-Leber congenital amaurosis(LCA10) [J]. Invest Ophthalmol Visual Sci,2022, 63(7): 3843., articleTitle=null, refAbstract=null), Reference(id=1330233156222956495, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=HEON E, ALABDULJALIL T, MCGUIGAN Ⅲ D B, et al. Visual function and central retinal structure in choroideremia[J]. Invest Ophthalmol Visual Sci, 2016, 57(9): OCT377-OCT387., articleTitle=null, refAbstract=null), Reference(id=1330233156281676752, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=ABBOUDA A, AVOGARO F, MOOSAJEE M, et al. Update on gene therapy clinical trials for choroideremia and potential experimental therapies [J]. Medicina (Kaunas),2021, 57(1): 64., articleTitle=null, refAbstract=null), Reference(id=1330233156348785617, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=CWERMAN-THIBAULT H, AUGUSTIN S, ELLOUZE S, et al. Gene therapy for mitochondrial diseases: Leber hereditary optic neuropathy as the first candidate for a clinical trial [J]. C R Biol, 2014, 337(3): 193-206., articleTitle=null, refAbstract=null), Reference(id=1330233156415894482, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=ARTIKA I M. Allotopic expression of mitochondrial genes:basic strategy and progress [J]. Genes Dis, 2020, 7(4):578-584., articleTitle=null, refAbstract=null), Reference(id=1330233156499780563, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=BONNET C, KALTIMBACHER V, ELLOUZE S, et al. Allotopic mRNA localization to the mitochondrial surface rescues respiratory chain defects in fibroblasts harboring mitochondrial DNA mutations affecting complexⅠorⅤsubunits [J]. Rejuvenation Res, 2007,10(2): 127-144., articleTitle=null, refAbstract=null), Reference(id=1330233156571083732, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=GUY J, QI X P, KOILKONDA R D, et al. Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system [J]. Invest Ophthalmol Visual Sci, 2009, 50(9): 4205-4214., articleTitle=null, refAbstract=null), Reference(id=1330233156646581205, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=KOILKONDA R, YU H, TALLA V, et al. LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA:biodistribution and toxicology profile [J]. Invest Ophthalmol Visual Sci, 2014, 55(12): 7739-7753., articleTitle=null, refAbstract=null), Reference(id=1330233156705301462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=LAM B L, FEUER W J, DAVIS J L, et al. Leber hereditary optic neuropathy gene therapy: adverse events and visual acuity results of all patient groups [J]. Am J Ophthalmol,2022, 241: 262-271., articleTitle=null, refAbstract=null), Reference(id=1330233156772410327, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=THOMASSON N, GALY A, FITOUSSI S, et al. Relevance of NHP safety studies for ocular delivery of AAV-based gene therapy in humans: example of GS010(rAAV2/2-ND4) local tolerability, shedding and immunogenicity for the treatment of Leber hereditary optic neuropathy(LHON), after intravitreal(IVT) injection in non-human primates(NHP) and in LHON patients [J]. Invest Ophthalmol Visual Sci,2015, 56(7): 1087., articleTitle=null, refAbstract=null), Reference(id=1330233156839519192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=YUAN J J, ZHANG Y, LIU H L, et al. Seven-year follow-up of gene therapy for Leber’s hereditary optic neuropathy[J]. Ophthalmology, 2020, 127(8): 1125-1127., articleTitle=null, refAbstract=null), Reference(id=1330233156898239449, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=AURICCHIO A, KOBINGER G, ANAND V, et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model [J]. Hum Mol Genet, 2001, 10(26): 3075-3081., articleTitle=null, refAbstract=null), Reference(id=1330233156973736922, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=LEBHERZ C, MAGUIRE A, TANG W X, et al. Novel AAV serotypes for improved ocular gene transfer [J]. J Gene Med, 2008, 10(4): 375-382., articleTitle=null, refAbstract=null), Reference(id=1330233157028262875, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=MACLAREN R E, GROPPE M, BARNARD A R, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial [J]. The Lancet,2014, 383(9923): 1129-1137., articleTitle=null, refAbstract=null), Reference(id=1330233157082788828, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=BAINBRIDGE J W B, MEHAT M S, SUNDARAM V, et al. Long-term effect of gene therapy on Leber’s congenital amaurosis [J]. N Engl J Med, 2015, 372(20): 1887-1897., articleTitle=null, refAbstract=null), Reference(id=1330233157141509085, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=TESTA F, MAGUIRE A M, ROSSI S, et al. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2 [J]. Ophthalmology, 2013, 120(6): 1283-1291., articleTitle=null, refAbstract=null), Reference(id=1330233157200229342, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=HINDERER C, KATZ N, BUZA E L, et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN [J]. Hum Gene Ther, 2018,29(3): 285-298., articleTitle=null, refAbstract=null), Reference(id=1330233157258949599, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=NGUYEN G N, EVERETT J K, KAFLE S, et al. A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells [J]. Nat Biotechnol, 2021, 39(1): 47-55., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330233151953154983, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, awardId=BM2021002, language=CN, fundingSource=江苏省新药一站式高效非临床评价公共服务平台建设项目(BM2021002), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330233148199252850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=1., ext=[AuthorCompanyExt(id=1330233148207641459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013), AuthorCompanyExt(id=1330233148216030068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.安徽中医药大学药学院,安徽 合肥 230013)]), AuthorCompany(id=1330233148295721845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=2., ext=[AuthorCompanyExt(id=1330233148308304758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Yangtze Delta Pharmaceutical College, Nantong 226133), AuthorCompanyExt(id=1330233148320887671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南通市海门长三角药物高等研究院,江苏 南通 226133)]), AuthorCompany(id=1330233148392190840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=3., ext=[AuthorCompanyExt(id=1330233148404773753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000), AuthorCompanyExt(id=1330233148413162362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.益诺思生物技术南通有限公司,江苏 南通 226000)]), AuthorCompany(id=1330233148484465531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=4., ext=[AuthorCompanyExt(id=1330233148492854140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148484465531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shanghai InnoStar Bio-Tech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330233148501242749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148484465531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.中国医药工业研究总院上海益诺思生物技术股份有限公司,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.10.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.10.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.10.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.10.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1696867200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
遗传性视网膜疾病基因治疗的研究进展
刘楚乔 1, 2, 3 , 张鹏 2, 3 , 付莉莉 1, 2, 3 , 陶巧玉 1, 2, 3 , 邱云良 3, 4, *
中国医药工业杂志 | 综述 2023,54(10): 1403-1410
收起
收藏切换
中国医药工业杂志 |综述 2023 , 54 (10) : 1403 -1410
遗传性视网膜疾病基因治疗的研究进展
全屏
[Author(id=1330233148580934527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233148685792131, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233148580934527, language=EN, stringName=Chuqiao LIU, firstName=Chuqiao, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013
2.Yangtze Delta Pharmaceutical College, Nantong 226133
3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233148757095300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233148580934527, language=CN, stringName=刘楚乔, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.安徽中医药大学药学院,安徽 合肥 230013
2.南通市海门长三角药物高等研究院,江苏 南通 226133
3.益诺思生物技术南通有限公司,江苏 南通 226000, bio={"content":"

刘楚乔(1995—),女,硕士,从事药理学研究。

"}, bioImg=null, bioContent=

刘楚乔(1995—),女,硕士,从事药理学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233148199252850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=1., ext=[AuthorCompanyExt(id=1330233148207641459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013), AuthorCompanyExt(id=1330233148216030068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.安徽中医药大学药学院,安徽 合肥 230013)]), AuthorCompany(id=1330233148295721845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=2., ext=[AuthorCompanyExt(id=1330233148308304758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Yangtze Delta Pharmaceutical College, Nantong 226133), AuthorCompanyExt(id=1330233148320887671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南通市海门长三角药物高等研究院,江苏 南通 226133)]), AuthorCompany(id=1330233148392190840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=3., ext=[AuthorCompanyExt(id=1330233148404773753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000), AuthorCompanyExt(id=1330233148413162362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.益诺思生物技术南通有限公司,江苏 南通 226000)])]), Author(id=1330233148824204166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233148899701641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233148824204166, language=EN, stringName=Peng ZHANG, firstName=Peng, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2.Yangtze Delta Pharmaceutical College, Nantong 226133
3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233148954227594, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233148824204166, language=CN, stringName=张鹏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2.南通市海门长三角药物高等研究院,江苏 南通 226133
3.益诺思生物技术南通有限公司,江苏 南通 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233148295721845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=2., ext=[AuthorCompanyExt(id=1330233148308304758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Yangtze Delta Pharmaceutical College, Nantong 226133), AuthorCompanyExt(id=1330233148320887671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南通市海门长三角药物高等研究院,江苏 南通 226133)]), AuthorCompany(id=1330233148392190840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=3., ext=[AuthorCompanyExt(id=1330233148404773753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000), AuthorCompanyExt(id=1330233148413162362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.益诺思生物技术南通有限公司,江苏 南通 226000)])]), Author(id=1330233149029725068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233149138776976, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149029725068, language=EN, stringName=Lili FU, firstName=Lili, middleName=null, lastName=FU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013
2.Yangtze Delta Pharmaceutical College, Nantong 226133
3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233149210080145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149029725068, language=CN, stringName=付莉莉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.安徽中医药大学药学院,安徽 合肥 230013
2.南通市海门长三角药物高等研究院,江苏 南通 226133
3.益诺思生物技术南通有限公司,江苏 南通 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233148199252850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=1., ext=[AuthorCompanyExt(id=1330233148207641459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013), AuthorCompanyExt(id=1330233148216030068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.安徽中医药大学药学院,安徽 合肥 230013)]), AuthorCompany(id=1330233148295721845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=2., ext=[AuthorCompanyExt(id=1330233148308304758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Yangtze Delta Pharmaceutical College, Nantong 226133), AuthorCompanyExt(id=1330233148320887671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南通市海门长三角药物高等研究院,江苏 南通 226133)]), AuthorCompany(id=1330233148392190840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=3., ext=[AuthorCompanyExt(id=1330233148404773753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000), AuthorCompanyExt(id=1330233148413162362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.益诺思生物技术南通有限公司,江苏 南通 226000)])]), Author(id=1330233149285577619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233149369463703, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149285577619, language=EN, stringName=Qiaoyu TAO, firstName=Qiaoyu, middleName=null, lastName=TAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013
2.Yangtze Delta Pharmaceutical College, Nantong 226133
3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233149436572568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149285577619, language=CN, stringName=陶巧玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.安徽中医药大学药学院,安徽 合肥 230013
2.南通市海门长三角药物高等研究院,江苏 南通 226133
3.益诺思生物技术南通有限公司,江苏 南通 226000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233148199252850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=1., ext=[AuthorCompanyExt(id=1330233148207641459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013), AuthorCompanyExt(id=1330233148216030068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148199252850, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.安徽中医药大学药学院,安徽 合肥 230013)]), AuthorCompany(id=1330233148295721845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=2., ext=[AuthorCompanyExt(id=1330233148308304758, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Yangtze Delta Pharmaceutical College, Nantong 226133), AuthorCompanyExt(id=1330233148320887671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148295721845, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南通市海门长三角药物高等研究院,江苏 南通 226133)]), AuthorCompany(id=1330233148392190840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=3., ext=[AuthorCompanyExt(id=1330233148404773753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000), AuthorCompanyExt(id=1330233148413162362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.益诺思生物技术南通有限公司,江苏 南通 226000)])]), Author(id=1330233149495292826, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=ylqiu@innostar.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233149583373213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149495292826, language=EN, stringName=Yunliang QIU, firstName=Yunliang, middleName=null, lastName=QIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, 4, *, address=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000
4.Shanghai InnoStar Bio-Tech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233149650482078, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, authorId=1330233149495292826, language=CN, stringName=邱云良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, 4, *, address=3.益诺思生物技术南通有限公司,江苏 南通 226000
4.中国医药工业研究总院上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233148392190840, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=3., ext=[AuthorCompanyExt(id=1330233148404773753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000), AuthorCompanyExt(id=1330233148413162362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148392190840, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.益诺思生物技术南通有限公司,江苏 南通 226000)]), AuthorCompany(id=1330233148484465531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, xref=4., ext=[AuthorCompanyExt(id=1330233148492854140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148484465531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shanghai InnoStar Bio-Tech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330233148501242749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233147515581295, companyId=1330233148484465531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.中国医药工业研究总院上海益诺思生物技术股份有限公司,上海 201203)])])]
刘楚乔1, 2, 3, 张鹏2, 3, 付莉莉1, 2, 3, 陶巧玉1, 2, 3, 邱云良3, 4, *
作者信息
  • 1.安徽中医药大学药学院,安徽 合肥 230013
  • 2.南通市海门长三角药物高等研究院,江苏 南通 226133
  • 3.益诺思生物技术南通有限公司,江苏 南通 226000
  • 4.中国医药工业研究总院上海益诺思生物技术股份有限公司,上海 201203
通讯作者:
邱云良(1978—),男,研究员,从事药物毒理学研究。E-mail:
作者简介:

刘楚乔(1995—),女,硕士,从事药理学研究。

Advances in Gene Therapy for Inherited Retinal Diseases
Chuqiao LIU1, 2, 3, Peng ZHANG2, 3, Lili FU1, 2, 3, Qiaoyu TAO1, 2, 3, Yunliang QIU3, 4, *
Affiliations
  • 1.School of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230013
  • 2.Yangtze Delta Pharmaceutical College, Nantong 226133
  • 3.InnoStar Biotechnology Nantong Co., Ltd., Nantong 226000
  • 4.Shanghai InnoStar Bio-Tech Co., Ltd., China State Institute of Pharmaceutical Industry, Shanghai 201203
出版时间: 2023-10-10 doi: 10.16522/j.cnki.cjph.2023.10.001
文章导航
收藏切换

遗传性视网膜疾病(IRD)是造成患者不可逆视力丧失或失明的重要原因,其预后差,临床缺乏有效的干预手段。基因治疗药物为该类疾病治疗创造了新的可能。腺相关病毒(AAV)是目前基因治疗中应用较广泛、较有前景的病毒载体之一。该文简述了AVV载体眼部应用的可行性,重点阐述了应用AAV递送系统治疗IRD的临床前及临床进展,并结合取得的数据评估其安全性及有效性。最后总结了基因治疗IRD的影响因素,展望今后的研究方向,以期为IRD治疗技术创新、AAV载体后续产品研发提供参考。

遗传性视网膜疾病  /  腺相关病毒  /  基因治疗  /  安全性

Inherited retinal diseases(IRD) are an important cause of irreversible vision loss or blindness, whose prognosis is poor, and clinically effective intervention methods are lacking. Gene therapy has created new possibilities for IRD treatment. Adeno-associated viral(AAV) is a widely used viral gene therapy vector with application prospects. This paper briefly describes the feasibility of AVV vectors in ocular application, focuses on the preclinical and clinical progress of the application of AAV delivery system for IRD treatment, evaluates the safety and efficacy based on the obtained data, and summarizes the influencing factors of gene therapy for IRD, as well as looks forward to the future research directions, providing references for the technological innovation of IRD treatment and the subsequent product development of AAV vectors.

inherited retinal disease  /  adeno-associated viral  /  gene therapy  /  safety
刘楚乔, 张鹏, 付莉莉, 陶巧玉, 邱云良. 遗传性视网膜疾病基因治疗的研究进展. 中国医药工业杂志, 2023 , 54 (10) : 1403 -1410 . DOI: 10.16522/j.cnki.cjph.2023.10.001
Chuqiao LIU, Peng ZHANG, Lili FU, Qiaoyu TAO, Yunliang QIU. Advances in Gene Therapy for Inherited Retinal Diseases[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (10) : 1403 -1410 . DOI: 10.16522/j.cnki.cjph.2023.10.001
  • 江苏省新药一站式高效非临床评价公共服务平台建设项目(BM2021002)
参考文献 引证文献
排序方式:
[1]
GALVIN O, CHI G, BRADY L, et al. The impact of inherited retinal diseases in the Republic of Ireland(ROI) and the United Kingdom(UK) from a cost-of-illness perspective[J]. Clin Ophthalmol, 2020, 14: 707-719.
[2]
GONG J, CHEUNG S, FASSO-OPIE A, et al. The impact of inherited retinal diseases in the United States of America(US) and Canada from a cost-of-illness perspective[J]. Clin Ophthalmol, 2021, 15: 2855-2866.
[3]
FENNER B J, TAN T E, BARATHI A V, et al. Gene-based therapeutics for inherited retinal diseases [J]. Front Genet,2022, 12: 794805.
[4]
HANANY M, RIVOLTA C, SHARON D. Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases [J]. Proc Natl Acad Sci U S A, 2020, 117(5): 2710-2716.
[5]
DIAKATOU M, MANES G, BOCQUET B, et al. Genome editing as a treatment for the most prevalent causative genes of autosomal dominant retinitis pigmentosa [J]. Int J Mol Sci, 2019, 20(10): 2542.
[6]
RIVOLTA C, SHARON D, DEANGELIS M M, et al. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns [J]. Hum Mol Genet, 2002,11(10): 1219-1227.
[7]
DAIGER S P, SULLIVAN L S, BOWNE S J. Genes and mapped loci causing retinal diseases [EB/OL]. (2022-10-07)[2022-10-17]. https://web.sph.uth.edu/RetNet/disease.htm.
[8]
KEELER A M, FLOTTE T R. Recombinant adeno-associated virus gene therapy in light of Luxturna(and Zolgensma and Glybera): where are we, and how did we get here? [J]. Annu Rev Virol, 2019, 6(1): 601-621.
[9]
WANG Y H, RAJALA A, CAO B, et al. Cell-specific promoters enable lipid-based nanoparticles to deliver genes to specific cells of the retina in vivo [J]. Theranostics, 2016,6(10): 1514-1527.
[10]
REN D H, FISSON S, DALKARA D, et al. Immune responses to gene editing by viral and non-viral delivery vectors used in retinal gene therapy [J]. Pharmaceutics,2022, 14(9): 1973.
[11]
APAOLAZA P S, DELGADO D, DEL POZO-RODRÍGUEZ A, et al. A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases [J]. Int J Pharm, 2014, 465(1/2): 413-426.
[12]
PURAS G, MASHAL M, ZÁRATE J, et al. A novel cationic niosome formulation for gene delivery to the retina [J]. J Control Release, 2014, 174: 27-36.
[13]
AIL D, MALKI H, ZIN E A, et al. Adeno-associated virus(AAV)-based gene therapies for retinal diseases: where are we? [J]. Appl Clin Genet, 2023, 16: 111-130.
[14]
GHOSH A, YUE Y, LAI Y, et al. A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner [J]. Mol Ther, 2008,16(1): 124-130.
[15]
滕小龙,史硕博.CRISPR/Cas9 系统在基因组编辑中的优化与发展[J].合成生物学,2023,4(1):67-85.
[16]
LEROY B P, FISCHER M D, FLANNERY J G, et al. Gene therapy for inherited retinal disease: long-term durability of effect [J]. Ophthalmic Res, 2023, 66(1): 179-196.
[17]
DHOOGE P P, VALKENBURG D, HOYNG C B. Gene therapy for inherited retinal diseases [M]// GAO X R. Genetics and genomics of eye disease. Amsterdam: Elsevier,2020: 279-295.
[18]
HAMEL C. Retinitis pigmentosa [J]. Orphanet J Rare Dis, 2006, 1(1): 40.
[19]
沈科炯,沈吟.遗传性视网膜疾病腺相关病毒载体基因治疗新进展[J].中华眼底病杂志,2020,36(3):242-248.
[20]
MERCAU M E, AKALU Y T, MAZZONI F, et al. Inflammation of the retinal pigment epithelium drives early-onset photoreceptor degeneration in MERTK-associated retinitis pigmentosa [J]. Sci Adv, 2023, 9(3): eade9459.
[21]
GHAZI N G, ABBOUD E B, NOWILATY S R, et al. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phaseⅠtrial [J]. Hum Genet, 2016, 135(3): 327-343.
[22]
HERNÁNDEZ-JUÁREZ J, RODRíGUEZ-URIBE G, BOROOAH S. Toward the treatment of inherited diseases of the retina using CRISPR-based gene editing [J]. Front Med (Lausanne), 2021, 8: 698521.
[23]
SUZUKI K, TSUNEKAWA Y, HERNANDEZ-BENITEZ R, et al. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration [J]. Nature,2016, 540(7631): 144-149.
[24]
DE SILVA S R, ARNO G, ROBSON A G, et al. The X-linked retinopathies: physiological insights, pathogenic mechanisms, phenotypic features and novel therapies [J]. Prog Retinal Eye Res, 2021, 82: 100898.
[25]
CEHAJIC-KAPETANOVIC J, XUE K, MARTINEZ-FERNANDEZ DE LA CAMARA C, et al. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR [J]. Nat Med,2020, 26(3): 354-359.
[26]
MARTINEZ VELAZQUEZ L A, BALLIOS B G. The next generation of molecular and cellular therapeutics for inherited retinal disease [J]. Int J Mol Sci, 2021, 22(21): 11542.
[27]
WU Y D, WAN X L, ZHAO D D, et al. AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa [J]. Nat Commun,2023, 14(1): 4923.
[28]
KISER P D. Retinal pigment epithelium 65 kDa protein(RPE65): an update [J]. Prog Retinal Eye Res,2022, 88: 101013.
[29]
PANG J J, CHANG B, HAWES N L, et al. Retinal degeneration 12(rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis(LCA) [J]. Mol Vis, 2005, 11(17): 152-162.
[30]
LAI C M, YU M J, BRANKOV M, et al. Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65 - / - knockout mouse eye results in limited rescue [J]. Genet Vaccines Ther, 2004, 2(1): 3.
[31]
ACLAND G M, AGUIRRE G D, BENNETT J, et al. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness [J]. Mol Ther, 2005, 12(6): 1072-1082.
[32]
WELEBER R G, PENNESI M E, WILSON D J, et al. Results at 2 years after gene therapy for RPE65-deficient Leber congenital amaurosis and severe early-childhood-onset retinal dystrophy [J]. Ophthalmology, 2016, 123(7): 1606-1620.
[33]
PENNESI M E, WELEBER R G, YANG P, et al. Results at 5 years after gene therapy for RPE65-deficient retinal dystrophy [J]. Hum Gene Ther, 2018, 29(12): 1428-1437.
[34]
JO D H, SONG D W, CHO C S, et al. CRISPR-Cas9-mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis[J]. Sci Adv, 2019, 5(10): eaax1210.
[35]
MAEDER M L, STEFANIDAKIS M, WILSON C J, et al. Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10 [J]. Nat Med,2019, 25(2): 229-233.
[36]
PHILIPPIDIS A. One small dose, one giant leap for CRISPR gene editing [J]. Hum Gene Ther, 2020, 31(7/8):402-404.
[37]
LEON L M, ZHANG W, SAHU B, et al. A MiniCEP290 gene replacement therapy to treat CEP290-Leber congenital amaurosis(LCA10) [J]. Invest Ophthalmol Visual Sci,2022, 63(7): 3843.
[38]
HEON E, ALABDULJALIL T, MCGUIGAN Ⅲ D B, et al. Visual function and central retinal structure in choroideremia[J]. Invest Ophthalmol Visual Sci, 2016, 57(9): OCT377-OCT387.
[39]
ABBOUDA A, AVOGARO F, MOOSAJEE M, et al. Update on gene therapy clinical trials for choroideremia and potential experimental therapies [J]. Medicina (Kaunas),2021, 57(1): 64.
[40]
CWERMAN-THIBAULT H, AUGUSTIN S, ELLOUZE S, et al. Gene therapy for mitochondrial diseases: Leber hereditary optic neuropathy as the first candidate for a clinical trial [J]. C R Biol, 2014, 337(3): 193-206.
[41]
ARTIKA I M. Allotopic expression of mitochondrial genes:basic strategy and progress [J]. Genes Dis, 2020, 7(4):578-584.
[42]
BONNET C, KALTIMBACHER V, ELLOUZE S, et al. Allotopic mRNA localization to the mitochondrial surface rescues respiratory chain defects in fibroblasts harboring mitochondrial DNA mutations affecting complexⅠorⅤsubunits [J]. Rejuvenation Res, 2007,10(2): 127-144.
[43]
GUY J, QI X P, KOILKONDA R D, et al. Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system [J]. Invest Ophthalmol Visual Sci, 2009, 50(9): 4205-4214.
[44]
KOILKONDA R, YU H, TALLA V, et al. LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA:biodistribution and toxicology profile [J]. Invest Ophthalmol Visual Sci, 2014, 55(12): 7739-7753.
[45]
LAM B L, FEUER W J, DAVIS J L, et al. Leber hereditary optic neuropathy gene therapy: adverse events and visual acuity results of all patient groups [J]. Am J Ophthalmol,2022, 241: 262-271.
[46]
THOMASSON N, GALY A, FITOUSSI S, et al. Relevance of NHP safety studies for ocular delivery of AAV-based gene therapy in humans: example of GS010(rAAV2/2-ND4) local tolerability, shedding and immunogenicity for the treatment of Leber hereditary optic neuropathy(LHON), after intravitreal(IVT) injection in non-human primates(NHP) and in LHON patients [J]. Invest Ophthalmol Visual Sci,2015, 56(7): 1087.
[47]
YUAN J J, ZHANG Y, LIU H L, et al. Seven-year follow-up of gene therapy for Leber’s hereditary optic neuropathy[J]. Ophthalmology, 2020, 127(8): 1125-1127.
[48]
AURICCHIO A, KOBINGER G, ANAND V, et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model [J]. Hum Mol Genet, 2001, 10(26): 3075-3081.
[49]
LEBHERZ C, MAGUIRE A, TANG W X, et al. Novel AAV serotypes for improved ocular gene transfer [J]. J Gene Med, 2008, 10(4): 375-382.
[50]
MACLAREN R E, GROPPE M, BARNARD A R, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial [J]. The Lancet,2014, 383(9923): 1129-1137.
[51]
BAINBRIDGE J W B, MEHAT M S, SUNDARAM V, et al. Long-term effect of gene therapy on Leber’s congenital amaurosis [J]. N Engl J Med, 2015, 372(20): 1887-1897.
[52]
TESTA F, MAGUIRE A M, ROSSI S, et al. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2 [J]. Ophthalmology, 2013, 120(6): 1283-1291.
[53]
HINDERER C, KATZ N, BUZA E L, et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN [J]. Hum Gene Ther, 2018,29(3): 285-298.
[54]
NGUYEN G N, EVERETT J K, KAFLE S, et al. A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells [J]. Nat Biotechnol, 2021, 39(1): 47-55.
2023年第54卷第10期
20
3
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.10.001
  • 接收时间:2022-12-02
  • 首发时间:2026-11-19
  • 出版时间:2023-10-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-12-02
基金
江苏省新药一站式高效非临床评价公共服务平台建设项目(BM2021002)
作者信息
    1.安徽中医药大学药学院,安徽 合肥 230013
    2.南通市海门长三角药物高等研究院,江苏 南通 226133
    3.益诺思生物技术南通有限公司,江苏 南通 226000
    4.中国医药工业研究总院上海益诺思生物技术股份有限公司,上海 201203

通讯作者:

邱云良(1978—),男,研究员,从事药物毒理学研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.10.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏